Skip to main content
SpringerLink
Log in

Basal or bolus dose, which is the key factor in CSII?

  • Published:
Journal of Zhejiang University SCIENCE B Aims and scope Submit manuscript

Abstract

Objective: To observe the value of HbA1c level evaluating the total daily basal insulin dose by continuous subcutaneous insulin infusion (CSII) in 268 patients with type 2 diabetes mellitus. Methods: 5-point capillary blood glucose was monitored in pre-and post-CSII and the insulin dose which could stabilize blood glucose was defined as the total daily dose of insulin, including basal and bolus total dose. Correlation between HbA1c level and total daily dose of insulin in patients with type 2 diabetes mellitus was analyzed. Correlation between HbA1c level and 5-point capillary blood glucose was also analyzed. Results: Obvious correlation was observed between HbA1c level and the basal total daily dose of insulin if HbA1c was more than 9.3% (r=0.635, P<0.05). The average of 5-point capillary blood glucose was best correlated with HbA1c and fasting blood glucose next best. Conclusion: HbA1c level can forecast basal total daily dose of insulin in CSII.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abbasi, F., Reaven, G.M., 2002. Relationship between fasting and day-long plasma glucose concentrations in diet-treated patients with type 2 diabetes. Metabolism, 51(4):457–459. [doi:10.1053/meta.2002.31325]

    Article  PubMed  CAS  Google Scholar 

  • Bonora, E., Calcaterra, F., Muggeo, M., 2001. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care, 24:2023–2029.

    PubMed  CAS  Google Scholar 

  • Crawford, L.M., Sinha, R.N., Odell, R.M., Comi, R.J., 2000. Efficacy of insulin pump therapy: mealtime delivery is the key factor. Endocr. Pract., 6(3):239–243.

    PubMed  CAS  Google Scholar 

  • Knee, T.S., Seidensticker, D.F., Walton, J.L., Solberg, L.M., Lasseter, D.H., 2003. A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series. Endocr. Pract., 9(3):181–186.

    PubMed  Google Scholar 

  • Monnier, L., Lapinski, H., Colette, C., 2003. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care, 26(3):881–885.

    PubMed  Google Scholar 

  • Zinman, B., 2000. Basal insulin replacement and use of rapid-acting insulin analogues in patients with type 1 diabetes. Endocr. Pract., 6(1):88–92.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, the Affiliated Hospital of Medical College, Qingdao University, Qingdao, 266003, China

    Yang Nai-long & Lin Peng

  2. Department of Endocrinology, Shenyang General Hospital, Shenyang, 110016, China

    Xue Bing

Authors
  1. Yang Nai-long
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xue Bing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lin Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, Nl., Xue, B. & Lin, P. Basal or bolus dose, which is the key factor in CSII?. J. Zhejiang Univ. - Sci. B 7, 763–765 (2006). https://doi.org/10.1631/jzus.2006.B0763

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.2006.B0763

Key words

CLC number

Search

Navigation